TTUHSC researcher receives patent for schistosomiasis vaccine - Lubbock AJ
Lubbock AJ - Dr. Afzal Siddiqui received patent for a vaccine he created through TTUHSC research to treat schistosomiasis.
The disease is more prevalent in countries outside the continental United States, potentially putting 800 million people at risk.
“This vaccine is a chance to improve the lives of 200 million people,” said Dr. Michael Conn, vice president of research for TTUHSC, in reference to the number of people affected by the disease. “This kind of opportunity doesn’t come along often.”
Related Stories
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Adopt a Growth Mindset for a Better Life
A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.
Drug Use, Family History Can Lead to Heart Disease in Younger Adults
Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.
Recent Stories
The TTUHSC Laura W. Bush Institute for Women’s Health Welcomes Ben Carson as Power of the Purse Keynote Speaker
Retired neurosurgeon and former U.S. Secretary of Housing and Urban Development Ben Carson, M.D., delivered a keynote address at the Power of the Purse luncheon and fundraiser today (April 18).
Filling the Gap: PA Impact on Rural Health Care
Assistant Professor and Director of Clinical Education Elesea Villegas, MPAS, PA-C, spoke about the challenges rural health care currently faces and how PAs are stepping up to better serve the rural patient population.
School of Pharmacy Remembers Contributions of Key Collaborator
Cynthia Nash, Pharm.D., served as an Adjunct Assistant Professor of Pharmacy Practice for the School, and was an instrumental collaborator and key ally in our partnership with the Dallas VA North Texas Health Care System.